Co-Authors
This is a "connection" page, showing publications co-authored by GARY E GALLICK and DAVID SANGHYUN HONG.
Connection Strength
0.176
-
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors. Invest New Drugs. 2013 Aug; 31(4):918-26.
Score: 0.108
-
Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol. 2006 Mar; 168(3):962-72.
Score: 0.068